The Future of Cresset?<br />Dr Robert Scoffin<br />Chief Executive Officer<br />
Customer Thanks<br />You are the reason we are here<br />Our motivation is to create the best possible tools to aid drug d...
2010-2011 Year In Review<br />Cresset<br />Business grew 25% from 2009 to 2010<br />Continued growth in 2011 – projecting ...
Diverse Cresset Users<br />Medicinal Chemists<br />Molecular Modellers<br />
Strategy for Growth<br />Consolidate our position in existing markets<br />Strengthen current tools<br />Look for other ap...
New delivery platforms<br />The latest addition to the Cresset team<br />The Cresset cow<br />Cluster On Wheels<br />Porta...
Scientific Focus<br />FF3<br />Free Dr Vinter up from mundane day-to-day activities to focus on completing FF3<br />Extens...
May the Force (field) be with you…<br />There’s a disturbance in the Nitrogen force<br />When will FF3 be ready?<br />
Scientific Focus<br />FF3<br />Free Dr Vinter up from mundane day-to-day activities to focus on completing FF3<br />Extens...
Ridley Scott’s Tribute to Andy<br />Tyrell: The light that burns twice as bright burns for half as long - and you have bur...
rob@cresset-group.com<br />Questions welcomed<br />
Upcoming SlideShare
Loading in...5
×

Rob Scoffin, Cresset, 'The Cresset Future'

1,007

Published on

Published in: Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,007
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Rob Scoffin, Cresset, 'The Cresset Future'

  1. 1. The Future of Cresset?<br />Dr Robert Scoffin<br />Chief Executive Officer<br />
  2. 2. Customer Thanks<br />You are the reason we are here<br />Our motivation is to create the best possible tools to aid drug discovery<br />Your input drives future developments<br />Your financial support enables us to keep the lights on<br />You are also the reason we will be here next year<br />Our ongoing commitment to maintaining the high quality of our solutions<br />Focus on innovation in both science and service<br />Returning value for your investment in us<br />
  3. 3. 2010-2011 Year In Review<br />Cresset<br />Business grew 25% from 2009 to 2010<br />Continued growth in 2011 – projecting > 35% 2010 to 2011<br />Strong additions to the team – Mike, Rae, Viv, Janany, Chris, Martin, Rachel.<br />Science<br />Extension of FieldAlign with 3D-QSAR methodology<br />On-going development of new application for ‘Molecular Designers’<br />Extended applications in peptide mimetics, drug re-profiling, etc.<br />Portfolio Expansion<br />Extended Professional Services/Consulting offerings – driven by Martin Slater, backed up by Chris Earnshaw, Andy, Rob, Tim & Mark<br />Software-as-a-Service (SaaS) offering of FieldScreen (initially – others to follow)<br />
  4. 4. Diverse Cresset Users<br />Medicinal Chemists<br />Molecular Modellers<br />
  5. 5. Strategy for Growth<br />Consolidate our position in existing markets<br />Strengthen current tools<br />Look for other applications we can build on the existing science<br />Further expand the science base of Cresset<br />Develop New Markets<br />Med. Chem focus through new applications<br />New users for existing technology: Patenting, In-Licencing, ADMET, etc.<br />Expanded Services Offerings<br />Consulting services around use of the applications<br />New delivery platforms for existing applications<br />
  6. 6. New delivery platforms<br />The latest addition to the Cresset team<br />The Cresset cow<br />Cluster On Wheels<br />Portable, on-demand computing infrastructure<br />Pre-loaded FieldScreen application and database<br />Plug-in and go capacity expansion<br />Secure – data on portable, removable drives<br />The Cresset COW<br />
  7. 7. Scientific Focus<br />FF3<br />Free Dr Vinter up from mundane day-to-day activities to focus on completing FF3<br />Extensive validation and testing cycle – aim to release in 2012<br />Re-Profiling/Re-Purposing<br />Extend applications in drug re-profiling<br />TSB funded project with Biolauncher to build re-profiling database and toolkits<br />Massively parallel computing<br />New initiative to re-code Cresset tools (initially FieldScreen, others to follow) to run on GPU’s<br />OpenCL implementation of the scoring functions<br />Fields/Field points on proteins<br />Further investigation and application of Field approach to protein surfaces and structures<br />
  8. 8. May the Force (field) be with you…<br />There’s a disturbance in the Nitrogen force<br />When will FF3 be ready?<br />
  9. 9. Scientific Focus<br />FF3<br />Free Dr Vinter up from mundane day-to-day activities to focus on completing FF3<br />Extensive validation and testing cycle – aim to release in 2012<br />Re-Profiling/Re-Purposing<br />Extend applications in drug re-profiling<br />TSB funded project with Biolauncher to build re-profiling database and toolkits<br />Massively parallel computing<br />New initiative to re-code Cresset tools (initially FieldScreen, others to follow) to run on GPU’s<br />OpenCL implementation of the scoring functions<br />Fields/Field points on proteins<br />Further investigation and application of Field approach to protein surfaces and structures<br />
  10. 10. Ridley Scott’s Tribute to Andy<br />Tyrell: The light that burns twice as bright burns for half as long - and you have burned so very, very brightly, Roy Andy. Look at you: you're the Prodigal Son; you're quite a prize! <br />Batty: I've done... questionable things. <br />Tyrell: Also extraordinary things; revel in your time. <br /> Andy Vinter<br />Batty: Nothing the God of biomechanicsdrug discovery wouldn't let you into heaven for. <br />
  11. 11. rob@cresset-group.com<br />Questions welcomed<br />
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×